Welcome to our dedicated page for Teleflex SEC filings (Ticker: TFX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading about the UroLift system鈥檚 market adoption or tracking how Teleflex segments perform in vascular access and anesthesia often means wading through hundreds of pages of SEC prose. Teleflex SEC filings explained simply is exactly what Stock Titan delivers.
Pain point: Clinical-stage disclosures, FDA milestones, and multi-segment revenue notes make Teleflex鈥檚 10-K and 10-Q uniquely dense. Finding risk factors tied to product recalls or pinpointing R&D outlays can take hours.
Solution: Our AI engine highlights every key figure, from catheter sales growth to UroLift reimbursement trends, inside each Teleflex annual report 10-K simplified and Teleflex quarterly earnings report 10-Q filing. AG真人官方-time alerts flag Teleflex 8-K material events explained鈥攖hink FDA clearances or supply-chain updates鈥攎inutes after they hit EDGAR.
- Instant dashboards for Teleflex insider trading Form 4 transactions and Teleflex executive stock transactions Form 4
- Segment breakouts and cash-flow trends via AI-powered summaries
- One-click access to the Teleflex proxy statement executive compensation discussion
Need speed? Teleflex Form 4 insider transactions real-time arrive on your screen seconds after filing. Need depth? Our narrative layer connects catheter demand shifts to margin swings, giving you a concise Teleflex earnings report filing analysis.
Whether you鈥檙e understanding Teleflex SEC documents with AI for competitive intel or just want a cleaner view of cash-to-capex ratios, Stock Titan replaces the scrolling with insight. No more digging through PDFs鈥攋ust the disclosures that move the medical-device market.
Janus Henderson Group plc is disclosed as a beneficial owner of Teleflex Incorporated common stock, reporting an aggregate 4,149,271 shares representing 9.4% of the class. The filing indicates no sole voting or dispositive power and instead reports shared voting and dispositive power over the reported shares.
The Janus Henderson Enterprise Fund is shown holding 2,885,870 shares (6.5%) with shared voting and dispositive power. The filing includes a certification that the shares were acquired and are held in the ordinary course of business and not to influence control. The document is signed by Kristin Mariani and contains a power of attorney authorizing certain officers to execute ownership filings.
Teleflex Inc. (TFX) Form 4: Director Stuart A. Randle executed an open-market purchase of 1,000 common shares on 08/05/2025 at a weighted-average price of $115.86 (trade range $115.53鈥�$116.06). The transaction is coded 鈥淧,鈥� confirming it was a direct鈥損urchase rather than an option exercise or gift. After the buy, Randle鈥檚 direct ownership rises to 7,547 shares, an increase of roughly 15% in his personal stake.
No derivative securities were involved and there were no dispositions. Insider buying鈥攅specially by an independent director鈥攃an serve as a modest positive signal of management confidence and alignment with shareholder interests, though the dollar value (~$116k) is not large relative to Teleflex鈥檚 market capitalization.
FAQ
What is the current stock price of Teleflex (TFX)?
What is the market cap of Teleflex (TFX)?
